Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 68, Issue 5, Pages 702-712
Publisher
Wiley
Online
2015-08-11
DOI
10.1111/his.12801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ID4: a new player in the cancer arena
- (2015) Oncotarget
- miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
- (2014) Elisabetta Crippa et al. PLoS One
- Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
- (2013) Rachel Greenup et al. ANNALS OF SURGICAL ONCOLOGY
- Id4 dependent acetylation restores mutant-p53 transcriptional activity
- (2013) Ashley E Knowell et al. Molecular Cancer
- Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer
- (2013) Nicholas C. Hsu et al. PLoS One
- Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines
- (2013) Daniele Fanale et al. Biomed Research International
- Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation
- (2012) Yong Hannah Wen et al. BREAST CANCER RESEARCH AND TREATMENT
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- BRCA2 Mutations and Triple-Negative Breast Cancer
- (2012) Peter Meyer et al. PLoS One
- Cooperativity of Rb, Brca1, and p53 in Malignant Breast Cancer Evolution
- (2012) Prashant Kumar et al. PLoS Genetics
- Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
- (2011) E. Comen et al. BREAST CANCER RESEARCH AND TREATMENT
- ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
- (2011) H.-M. Jeon et al. CANCER RESEARCH
- p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features
- (2011) E. Biganzoli et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women
- (2011) Eunjung Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
- (2010) Aye Aye Thike et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
- (2009) Aye Aye Thike et al. MODERN PATHOLOGY
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancer
- (2008) Erik Noetzel et al. BMC CANCER
- BRCA1 regulates human mammary stem/progenitor cell fate
- (2008) S. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now